The Story of the Magee Equations: The Ultimate in Applied Immunohistochemistry.

In the remaining 149 cases with residual disease, the ME3 score of >25 was significantly associated with shorter distant recurrence-free survival and showed a trend for shorter breast cancer-specific survival. 40 The ME3 results in the neoadjuvant setting are comparable with or even better than many different molecular tests that are used for predicting chemotherapy benefits in ER+ breast cancers (see Table 1 ). 39 – 48 WHY MAGEE EQUATIONS?

also in 53,322 other papers